Mino-Lokpotentialmarket>$1BWe had aphase 2btrial with100%efficacyMino-Lokis our leadassetWe haveenough cashto go wellinto 2023We willhaveexclusivityMino-WrapAn actualiMSCupdateMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"We will openupinternationalsites forMino-Lok trialOur Halo-Lido trial willhave finalpatient byend of 2022Not manycompaniesthis size with2 late stageassetsOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKwas thebest deal Iever madeI/ONTAKis our leadassetWe expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I'm ashareholdermyselfHemorrhoidsis a $2BmarketI/ONTAK'spotentialmarket is>$300mThere are noFDAapproveddrugs to treathemorrhoidsWe intendto submita BLA in2H 2022I won't diluteshareholdersInsidersinvested$26.5mMino-Lokpotentialmarket>$1BWe had aphase 2btrial with100%efficacyMino-Lokis our leadassetWe haveenough cashto go wellinto 2023We willhaveexclusivityMino-WrapAn actualiMSCupdateMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusForius"We will openupinternationalsites forMino-Lok trialOur Halo-Lido trial willhave finalpatient byend of 2022Not manycompaniesthis size with2 late stageassetsOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKwas thebest deal Iever madeI/ONTAKis our leadassetWe expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I'm ashareholdermyselfHemorrhoidsis a $2BmarketI/ONTAK'spotentialmarket is>$300mThere are noFDAapproveddrugs to treathemorrhoidsWe intendto submita BLA in2H 2022I won't diluteshareholdersInsidersinvested$26.5m

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Mino-Lok potential market >$1B
  2. We had a phase 2b trial with 100% efficacy
  3. Mino-Lok is our lead asset
  4. We have enough cash to go well into 2023
  5. We will have exclusivity
  6. Mino-Wrap
  7. An actual iMSC update
  8. Myron Holubiak and I founded a private company in 2013
  9. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  10. We will open up international sites for Mino-Lok trial
  11. Our Halo-Lido trial will have final patient by end of 2022
  12. Not many companies this size with 2 late stage assets
  13. Only biotech with 2 Myron's on the leadership team
  14. I/ONTAK was the best deal I ever made
  15. I/ONTAK is our lead asset
  16. We expect to finish the Mino-Lok trial this year
  17. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  18. I'm a shareholder myself
  19. Hemorrhoids is a $2B market
  20. I/ONTAK's potential market is >$300m
  21. There are no FDA approved drugs to treat hemorrhoids
  22. We intend to submit a BLA in 2H 2022
  23. I won't dilute shareholders
  24. Insiders invested $26.5m